tiprankstipranks
Trending News
More News >
Conmed (CNMD)
NYSE:CNMD
US Market
Advertisement

Conmed (CNMD) Earnings Dates, Call Summary & Reports

Compare
198 Followers

Earnings Data

Report Date
Jan 29, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.32
Last Year’s EPS
1.34
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and strategic initiatives aimed at improving long-term profitability and shareholder value. However, challenges such as tariff impacts on margins and a significant decrease in GAAP net income were noted. The shift in capital allocation from dividends to share repurchases indicates a strategic focus on enhancing financial flexibility.
Company Guidance
During the third quarter of fiscal 2025, CONMED reported total sales of approximately $338 million, reflecting a 6.7% increase year-over-year as reported and 6.3% growth in constant currency. The company's general surgery segment grew 6.9% globally on a constant currency basis, while the orthopedics segment delivered a 5.3% constant currency growth globally. Adjusted net income for the quarter was $33.4 million, showing a 2.2% year-over-year increase, and adjusted diluted earnings per share rose by 2.9% to $1.08. The company highlighted key growth drivers such as BioBrace and Foot and Ankle within the orthopedics portfolio, and Buffalo Filter and AirSeal in the general surgery portfolio. For Q4, CONMED projected revenue between $363 million and $370 million, and anticipated full-year 2025 revenue of $1.365 billion to $1.372 billion. Adjusted gross margin for Q4 was expected to be in the mid-55% range. The company also announced a shift in its capital allocation strategy, suspending its dividend in favor of a $150 million share repurchase program to enhance financial flexibility and create long-term shareholder value.
Strong Revenue Growth
Total sales for the third quarter were approximately $338 million, representing a 6.7% growth year-over-year as reported and 6.3% growth in constant currency.
Key Product Performance
General surgery grew 6.9% globally on a constant currency basis, and orthopedics delivered 5.3% constant currency growth globally.
Operational Improvements
Record manufacturing volumes for orthopedic products and a significant reduction in critical SKUs, indicating progress in supply chain improvements.
Strategic Portfolio Review
Engagement with top-tier consultants to assess product offerings, focusing on long-term return on invested capital and improving margin profile.
Share Repurchase Program
Board authorized a new $150 million share repurchase program, transitioning from legacy dividend policy to prioritize shareholder value.

Conmed (CNMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CNMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 29, 2026
2025 (Q4)
1.32 / -
1.34
Nov 05, 2025
2025 (Q3)
1.06 / 1.08
1.052.86% (+0.03)
Jul 30, 2025
2025 (Q2)
1.12 / 1.15
0.9817.35% (+0.17)
Apr 30, 2025
2025 (Q1)
0.81 / 0.95
0.7920.25% (+0.16)
Feb 05, 2025
2024 (Q4)
1.20 / 1.34
1.0626.42% (+0.28)
Oct 30, 2024
2024 (Q3)
1.02 / 1.05
0.916.67% (+0.15)
Jul 31, 2024
2024 (Q2)
0.91 / 0.98
0.8318.07% (+0.15)
Apr 24, 2024
2024 (Q1)
0.74 / 0.79
0.6619.70% (+0.13)
Jan 31, 2024
2023 (Q4)
1.11 / 1.06
0.42152.38% (+0.64)
Oct 25, 2023
2023 (Q3)
0.84 / 0.90
0.7716.88% (+0.13)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CNMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$44.44$44.21-0.52%
Jul 30, 2025
$49.95$50.96+2.02%
Apr 30, 2025
$48.75$56.77+16.45%
Feb 05, 2025
$73.20$66.63-8.98%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Conmed (CNMD) report earnings?
Conmed (CNMD) is schdueled to report earning on Jan 29, 2026, After Close (Confirmed).
    What is Conmed (CNMD) earnings time?
    Conmed (CNMD) earnings time is at Jan 29, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CNMD EPS forecast?
          CNMD EPS forecast for the fiscal quarter 2025 (Q4) is 1.32.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis